The latest market report published by Acute Market Reports “Global Laxatives Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the laxatives market was valued at USD 4,739.42 Mn in 2015, and is expected to reach USD 6,948.07 Mn by 2022, expanding at a CAGR of 5.6% from 2016 to 2022.
The laxative market is of paramount importance in facilitating the alleviation of constipation and associated gastrointestinal complications. From 2024 to 2032, the laxative market is anticipated to expand at a compound annual growth rate (CAGR) of 6.1%, propelled by rising health consciousness and evolving lifestyles. In the period between 2024 and 2032, it is anticipated that the market will further develop, characterized by formulation innovations and an expanded spectrum of applications.
According to a new market report published by Credence Research “Fumaric Acid Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 - 2021,” the fumaric acid market was valued at US$ 3.70 Bn in 2015, and is expected to reach US$ 5.69 Bn by 2022, expanding at a CAGR of 6.3% from 2016 to 2022.
According to a new market report published by Credence Research, “Fumaric Acid Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 - 2021,” the demand for fumaric acid is anticipated to witness high demand due to increase in use of processed food in the developed and developing region. Changing food patterns of people according to their busy lifestyle has driven the market for processed foods, thereby leading to high demand for fumaric acid in the market.
The latest market report published by Acute Market Reports “Opioid Induced Constipation (OIC) Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2022-2030,” the opioid induced constipation drugs market is expected to reach USD 4,399.1 Mn by 2030, expanding at a CAGR of 4.7% from 2022 to 2030.
The latest market report published by Acute Market Reports “Global Opioid Induced Constipation Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2022-2030,” the opioid induced constipation drugs market is expected to reach USD 4399.1 Mn by 2030, expanding at a CAGR of 4.6% from 2016 to 2022.
The latest market report published by Acute Market Reports, Inc. “Global Chronic Idiopathic Constipation (CIC) Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2022-2030,” the chronic idiopathic constipation (CIC) drugs market is expected to reach USD 4,222.81 Mn by 2030, expanding at a CAGR of 6.4% from 2022 to 2030; where Europe has the largest market share.
The latest market report published by Acute Market Reports, Inc. “Global Chronic Idiopathic Constipation (CIC) Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2022-2030,” the chronic idiopathic constipation drugs market is expected to reach USD 4,222.81 Mn by 2030, expanding at a CAGR of 6.4% from 2022 to 2030.
The latest market report published by Acute Market Reports “Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the irritable bowel syndrome with diarrhea (IBS-D) drugs market was valued at USD 289.3 Mn in 2015, and is expected to reach USD 1,115.06 Mn by 2022, expanding at a CAGR of 13.89% from 2016 to 2022.
The latest market report published by Acute Market Reports “Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2020-2028,” the irritable bowel syndrome with diarrhea drugs market was valued at USD 423.3 Mn in 2019, and is expected to reach USD 1,103.1 Mn by 2028, expanding at a CAGR of 11.3% from 2020 to 2028.
